PharmaAConsultancy ApS: Financial statements 2023
CVR: 42788341
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PharmaAConsultancy ApS (CVR 42788341) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 220,250 and a net result of DKK 135,673. The profit margin was 61.6%. Equity in the 2023 report amounted to DKK 207,967. The solvency ratio was 78.8%.
- Revenue
- DKK 220,250
- Gross Profit
- DKK 177,830
- Profit/Loss
- DKK 135,673
- Equity
- DKK 207,967
- Total Assets
- DKK 264,073
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PharmaAConsultancy ApS has published its interim report for the period October 26, 2021 to December 31, 2022.
About PharmaAConsultancy ApS
PharmaAConsultancy ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2021. The company is registered under the industry Anden undervisning i.a.n.. The management consists of Hashmatullah Nasimi and Khalid Essam Abdel-Raouf Amar. The company is owned by Khalid Essam Abdel-Raouf Amar and Hashmatullah Nasimi. The company has 2 employees (2025). In 2025, the company reported revenue of DKK 59,301 and a net result of DKK -81,144 compared with DKK -119,168 the year before. Equity in the 2025 report amounted to DKK 7,542.